[Invitation to Contributors]

The research and exploration in the cell industry are the anchor for the rapid growth of biopharmaceuticals and biotechnology. Beijing CytoNiche Biotechnology Co., Ltd. (“CytoNiche”), a 3D cell “intelligent manufacturing” expert, has broken the barriers in the process of constant innovations in research and development to share progresses and achievements enthusiastically.

To strengthen research and discussion exchanges and to deepen mutual understanding and attention across the industry, CytoNiche would like to extend an invitation to call on more researchers and technical experts from across the industry to share their experience and let their voices heard, creating more potential opportunities to let the cell industry bloom~

I. What is the deadline for my contribution?

From the date of release to December 31, 2023.

II. What are the specific criteria for my contribution?

1. CytoNiche’s products play a leading role in the research described in your article;

2. The company name, product model and product name of CytoNiche are mentioned in your article expressly;

3. Your article accurately describes relevant parameters, use conditions or patented technology of CyNiche products;

4. Your article should not contain products of manufacturers who are direct competitors of CytoNiche;

5. We have no restriction on the time of your publication, that is, the article that has been published is also eligible.

III. How do I send my contribution?

1. You may email your contribution to marketing@cytoniche.com;

2. You can submit your article to the staff of local CytoNiche office.

IV. What is my reward?

A shopping card worth RMB 1,500 / 3,000 / 5,000 will be rewarded, subject to your contribution type.

V. Is there anything else I should know?

Please refer to the “Contribution Incentives” for detailed requirements of contributions and rules for contribution incentives.

Follow us to learn more

CytoNiche reserves the right of the final interpretation of this Contribution Incentives.*

【CytoNiche】

Beijing CytoNiche Biotechnology Co., Ltd. was established by the research team of Professor Du Yanan from Tsinghua University School of Medicine, and was jointly established by Tsinghua University through equity participation. The core technologies were derived from the transformation of scientific and technological achievements of Tsinghua University. CytoNiche focuses on building an original 3D cell "smart manufacturing" platform, as well as providing overall solutions for the 3D microcarrier-based customized cell amplification process.

CytoNiche's core product, 3D TableTrix® Microcarrier Tablet (Microcarrier), is an independent innovation and the first pharmaceutical excipient grade microcarrier that can be used for cell drug development. It has obtained the certificate of analysis from relevant authoritative institutions such as National Institutes for Food and Drug Control, and obtained 2 qualifications for pharmaceutical excipients from the National Medical Products Administration (CDE approval registration number: F20210000003, F20200000496). Moreover, the product has obtained the DMF qualification for pharmaceutical excipients from U.S. FDA (DMF: 35481). 

Products and services of CytoNiche can be widely used in the upstream process development of gene and cell therapy, extracellular vesicles, vaccines, and protein products. At the same time, it also has broad prospects for applications in the fields of regenerative medicine, organoids, and food technology (cell-cultured meat, etc.).

Our company has a R&D and transformation platform of 5,000 square meters, including a CDMO platform of more than 1,000 square meters, a GMP production platform of 4,000 square meters, and a new 1200 L microcarrier production line. The relevant technologies have obtained more than 100 patents and more than 30 articles about the technologies in international journals have been published. The core technology projects have obtained a number of national-level project support and applications.